STOCK TITAN

Bio-Key International Inc. - BKYI STOCK NEWS

Welcome to our dedicated news page for Bio-Key International (Ticker: BKYI), a resource for investors and traders seeking the latest updates and insights on Bio-Key International.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Bio-Key International's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Bio-Key International's position in the market.

Rhea-AI Summary
BIO-key International, Inc. (NASDAQ: BKYI) announced the implementation of a Virtual Private Network (VPN) secured by BIO-key Swivel Secure authentication technology AuthControl Sentry for the Judiciary Police of Portugal, in collaboration with Securnet. The deployment significantly enhances operational security and efficiency for the Judiciary Police, supporting their fight against organized crime, terrorism, drug trafficking, corruption, and financial crimes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.33%
Tags
none
-
Rhea-AI Summary
BIO-key International, Inc. (NASDAQ: BKYI) announced a strategic collaboration with Carrefour, a leading global retailer, to integrate BIO-key’s AuthControl Sentry® cloud solution in Spain in collaboration with Evolutio. The solution will safeguard the authentication process for Carrefour’s 6,500 Spanish employees, reinforcing the company’s commitment to operational excellence and data security.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.91%
Tags
partnership
-
News
Rhea-AI Summary
BIO-key International, Inc. (NASDAQ: BKYI) announced the full repayment of its $2.2M senior secured note, eliminating all long-term debt, and completing a $550,000 private placement of units at a premium to market. The company's CEO, Michael DePasquale, highlighted the efforts to strengthen the company's financial position, including the completion of $4.3M in equity funding over the past two months.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.09%
Tags
none
Rhea-AI Summary
BIO-key International, Inc. (Nasdaq: BKYI) has approved a 1-for-18 reverse stock split to regain compliance with the minimum bid price requirement. The company had approximately 16.9 million shares of common stock issued and outstanding as of December 19, 2023, and will have approximately 941,000 shares after the reverse split. CEO Michael DePasquale stated that the decision was intended to position their common stock for ongoing minimum bid price compliance as they execute on their growth and profitability goals in 2024 and beyond.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1588.82%
Tags
none
-
Rhea-AI Summary
BIO-key International, Inc. (NASDAQ: BKYI) announced that Genesis HealthCare System, the largest healthcare provider in its six-county region of Ohio, will add BIO-key’s PortalGuard IAM platform to support its existing BIO-key biometric authentication investment as it migrates to Epic Systems’ Hyperdrive end-user application interface. This move allows Genesis HealthCare to continue enjoying the security and streamlined biometric authentication user experience that BIO-key provides without re-enrolling employees or adopting more cumbersome and expensive multi-factor authentication solutions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.33%
Tags
none
-
Rhea-AI Summary
BIO-key International, Inc. (Nasdaq: BKYI) partners with Ping Identity to integrate its unique biometric authentication technology with the PingOne Cloud Platform, enhancing security and user experience. The collaboration aims to offer organizations a powerful solution to shape the future of digital identity and contribute to a safer and more frictionless digital world.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.88%
Tags
partnership
Rhea-AI Summary
BIO-key® International, Inc. (Nasdaq: BKYI) announces sponsorship of Boston Cyber Security Summit to showcase its phoneless, tokenless, and passwordless Identity-Bound Biometric (IBB) multi-factor authentication (MFA) solutions. The event targets C-Level & Senior Executives and will feature FIDO2-compliant passwordless authentication options, including phoneless and tokenless MFA, along with traditional MFA approaches. BIO-key's IBB offers a true biometric passwordless authentication solution without the need for phones or tokens, addressing the need for phish-resistant MFA and passwordless authentication for users who cannot use phones or tokens to authenticate.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.11%
Tags
none
-
Rhea-AI Summary
BIO-key International, Inc. has been awarded an $800k order by a government defense ministry to accelerate the deployment of its biometric authentication solutions. This order, along with previous orders, is expected to be recognized in Q4'23. The defense ministry plans to expand the deployment to over 30,000 users and further programs, potentially leading to future awards. BIO-key's biometric authentication platform integrates with the ministry's virtual desktop infrastructure, providing secure access without the need for phones or tokens.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.52%
Tags
none
-
Rhea-AI Summary
BIO-key International, Inc. has closed its public offering of 21,430,000 units, each consisting of one share of common stock and one warrant. The units were sold at a price of $0.175 per unit, resulting in gross proceeds of approximately $3.75 million. The warrants are immediately exercisable at $0.175 per share and will expire in five years. Maxim Group LLC acted as the sole placement agent for the offering.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5%
Tags
offering
Rhea-AI Summary
BIO-key International, Inc. announces the pricing of its public offering of 21,430,000 units at a price of $0.175 per unit. The gross proceeds are expected to be approximately $3.75 million. The offering is expected to close on October 31, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-27.27%
Tags
offering
Bio-Key International Inc.

Nasdaq:BKYI

BKYI Rankings

BKYI Stock Data

3.80M
624.94k
4.77%
5.47%
1.86%
Software Publishers
Information
Link
US
Wall Township

About BKYI

bio-key international, inc. (otcqb: bkyi), is a trusted provider of enterprise and consumer biometric software and hardware authentication solutions. established in 1993 customers include the fortune 500, government agencies, healthcare organizations, call centers, schools, retailers, and oem partners. in 2016, the company introduced a line of compact fingerprint readers that have been tested and qualified for use with windows hello. these affordable and easy to install / easy to use readers are available through amazon, microsoft, dell.com and other leading retailers. at the consumer electronic show 2017, bio-key launched a series of biometric padlocks. touchlock won top product and was featured on more than 30+ morning television shows. looking into the future bio-key remains committed to developing the biometric of things (bot) a series of biometrically enabled consumer friendly products. all inspired by the power of a touch.